Healthy volunteers test injection devices for future eczema drug
NCT ID NCT07264335
First seen Jan 10, 2026 · Last updated May 18, 2026 · Updated 11 times
Summary
This early-stage study tests how a new drug (SHR-1819) enters the body when injected with different devices. It involves 160 healthy adults aged 18-55. The goal is to compare the drug's absorption and safety across devices, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The First Affiliated Hospital of University of Science and Technology of China
Hefei, Anhui, 230000, China
Conditions
Explore the condition pages connected to this study.